Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Preliminary results from CECILIA, an open-label global safety study of bevacizumab (BEV), carboplatin (C) and paclitaxel (P) therapy for metastatic, recurrent or persistent cervical cancer (CC).
PaperCitations, authors & open-access status
Preliminary results from CECILIA, an open-label global safety study of bevacizumab (BEV), carboplatin (C) and paclitaxel (P) therapy for metastatic, recurrent or persistent cervical cancer (CC). is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 5 citations, 2018 year and closed oa status.
5
Citations
2018
Year
closed
OA Status